Skip to main content
. 2023 Nov 30;109(6):1857–1865. doi: 10.3324/haematol.2023.283724

Figure 1.

Figure 1.

Outcomes for the whole population. Kaplan-Meier estimator of (A) progression-free survival and (B) overall survival for the whole population. Median follow-up was 115 months for surviving patients (N=37, 50%).